Indian Montelukast Exporters: Complete Supplier Ranking with Market Share — 1324 Manufacturers (2026) — TransData Nexus

Q: Who is the largest montelukast buyer importing from India?

AMERISOURCE HEALTH SERVICES (UNITED STATES) is the largest montelukast importer from India with a 17.3% market share and import value of $29.2M.

Q: How many montelukast buyers import from India?

There are 1324 active montelukast buyers importing from India, with a combined import market of $168.3M across 6,431 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top montelukast buyers from India?

The top 5 montelukast buyers — AMERISOURCE HEALTH SERVICES, MACLEODS PHARMA USA ,INC, BREATHEFREE LANKA PVT LTD, UNICHEM PHARMACEUTICALS (USA) INC., THE CATHAY DRUG CO. INC — together control 43.3% of total montelukast import value from India.

Suresh Sormare

Montelukast

India Pharmaceutical Trade Intelligence

$168.3M510 Suppliers138 CountriesHS 30049099

ExportsIndia → UNITED STATES58.1%India → PHILIPPINES7.9%

ImportsUNITED STATES → India$7.2K MALTA → India$6.9K

#1 Buyer: AMERISOURCE HEALTH

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $97.8M through 454 shipments. This represents a market share of 58.1% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• AMERISOURCE HEALTH SERVICES - $29.2M (29.9% of country's total business)

• MACLEODS PHARMA USA ,INC - $25.3M (25.9% of country's total business)

• UNICHEM PHARMACEUTICALS (USA) INC. - $6.3M (6.5% of country's total business)

• XXMBEXXPHAXXACEXXICAXX IXX - $3.8M (3.9% of country's total business)

• DR. REDDYS LABORATORIES, INC - $3.1M (3.2% of country's total business)

• Rest of United States's importers - $30.1M (30.7% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $215.4K, indicating premium pricing strategy compared to the market average of $26.2K.

United States is a key market for Montelukast imports, representing 58.1% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Montelukast buyer market intelligence

1Buyer Segment Analysis

The importers of Montelukast from India can be categorized into several key segments:

1. Distributors: These entities purchase Montelukast in bulk to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior is characterized by large-volume orders and a focus on cost-effectiveness to maintain competitive pricing. For instance, AMERISOURCE HEALTH SERVICES in the United States, with imports totaling $29.20 million, exemplifies this segment.

2. Pharmaceutical Companies: Companies like MACLEODS PHARMA USA, INC, which imported $25.30 million worth of Montelukast, may use the imported product for further processing, packaging, or direct distribution under their brand names. Their procurement patterns often involve consistent, large-scale purchases to meet production and market demands.

3. Hospital Groups and Healthcare Providers: These buyers procure Montelukast to meet the therapeutic needs of their patients. Their purchasing behavior is typically characterized by regular, moderate-sized orders aligned with patient demand and treatment protocols. While specific hospital groups are not listed among the top buyers, entities like THE CATHAY DRUG CO. INC in the Philippines, with imports of $4.16 million, may serve as suppliers to such institutions.

4. Government Procurement Agencies: Government bodies and international organizations often procure Montelukast through tenders to supply public health facilities and programs. Their buying patterns are influenced by public health policies, disease prevalence, and budget allocations. Although specific government agencies are not detailed in the top buyers, the presence of countries like the Philippines and Sri Lanka among the top importers suggests active government procurement.

5. Re-exporters: Some companies import Montelukast with the intent to re-export to other markets. Their purchasing behavior is driven by global market demands and trade agreements. Specific re-exporters are not identified in the provided data.

Country-Specific Import Regulations

TransData Nexus Montelukast buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Montelukast in the top importing countries is crucial for market entry and compliance.

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Montelukast is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs or a New Drug Application (NDA) for new drugs. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.

Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though this can vary.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

2. Philippines:

Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).

Demand Drivers & Market Opportunity

TransData Nexus Montelukast buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Montelukast in importing countries is influenced by several factors:

1. Disease Prevalence: Montelukast is primarily used to manage asthma and allergic rhinitis. According to the World Health Organization (WHO), asthma affected an estimated 262 million people globally in 2019, leading to 461,000 deaths. The high prevalence of respiratory conditions in countries like the United States and the Philippines drives the demand for effective treatments like Montelukast.

2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding their healthcare programs to achieve UHC, increasing access to essential medicines. For instance, the Philippines' Universal Health Care Act, enacted in 2019, aims to provide equitable access to quality and affordable health services, including essential medications. Such initiatives boost the procurement and distribution of drugs like Montelukast.

3. WHO Essential Medicines List (EML) Procurement: Montelukast is included in the WHO Model List of Essential Medicines, which guides countries in selecting medicines for their national formularies. Inclusion in the EML encourages governments and healthcare organizations to prioritize its procurement, ensuring wider availability.

4. Tender-Based Purchasing: Many countries and international organizations procure pharmaceuticals through tender systems to ensure cost-effectiveness and supply chain efficiency. For example, the WHO's Global Fund often utilizes tendering processes to procure medicines for large-scale health programs. Such mechanisms create substantial market opportunities for Montelukast suppliers.

With 1,324 buyers across 138 countries, the global market for Montelukast presents significant opportunities. Understanding the regulatory landscapes, demand drivers, and procurement mechanisms in key importing countries is essential for stakeholders aiming to navigate and succeed in this market.

Common Questions — Montelukast Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest montelukast buyer importing from India?

Based on import volume and value, AMERISOURCE HEALTH SERVICES (UNITED STATES) leads with $29.2M in imports and a 17.3% market share — the highest of any single montelukast importer. MACLEODS PHARMA USA ,INC (UNITED STATES) and BREATHEFREE LANKA PVT LTD (SRI LANKA) are the next largest buyers.

QHow many companies buy montelukast from India?

There are 1324 active montelukast buyers importing from India, with a combined market of $168.3M across 6,431 shipments to 138 countries. The top 5 buyers hold 43.3% of total import value, while the remaining 1319 buyers handle the other 56.7%.

QWhich countries import the most montelukast from India?

The top importing countries for montelukast from India are United States (58.1%), Philippines (7.9%), Sri Lanka (5.1%), United Kingdom (4.8%), South Africa (4.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of montelukast, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for montelukast from India?

The average import transaction value for montelukast from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Montelukast buyer market intelligence

1Buyer Segment Analysis

The importers of Montelukast from India can be categorized into several key segments:

Country-Specific Import Regulations

TransData Nexus Montelukast buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Montelukast in the top importing countries is crucial for market entry and compliance.

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though this can vary.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

2. Philippines:

Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).

Demand Drivers & Market Opportunity

TransData Nexus Montelukast buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Montelukast in importing countries is influenced by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Montelukast

Montelukast

Who Buys Montelukast from India — 1324 Importers Behind a $168.3M Market

Top Montelukast Importers — Ranked by Import Value

Top Montelukast Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Montelukast — and from which countries?

Montelukast — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Montelukast Buyers & Importers

QWho is the largest montelukast buyer importing from India?

QHow many companies buy montelukast from India?

QWhich countries import the most montelukast from India?

QWhat is the average import order value for montelukast from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Philippines

3Sri Lanka

4United Kingdom

5South Africa

Analysis Methodology